Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K4DI
|
||||
Former ID |
DAP001197
|
||||
Drug Name |
Anistreplase
|
||||
Therapeutic Class |
Thrombolytic Agents
|
||||
Formula |
C2569H3928N746O781S40
|
||||
CAS Number |
CAS 81669-57-0
|
||||
SuperDrug ATC ID |
B01AD03
|
||||
Target and Pathway | |||||
Target(s) | Plasminogen | Target Info | Activator | [537670], [538062] | |
PANTHER Pathway | Blood coagulation | ||||
Plasminogen activating cascade | |||||
PathWhiz Pathway | Coagulation | ||||
WikiPathways | Complement and Coagulation Cascades | ||||
Human Complement System | |||||
Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||||
Activation of Matrix Metalloproteinases | |||||
Blood Clotting Cascade | |||||
Dissolution of Fibrin Clot | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.